Sumayah Jamal

President, Co-Founder, Chief Scientific Officer at ENB Therapeutics - New York, NY, US

Sumayah Jamal's Colleagues at ENB Therapeutics
Sandy Harm

Chief Operating Officer

Contact Sandy Harm

Sumayah Jamal's Contact Details
HQ
212-792-2317
Location
New York,New York,United States
Company
ENB Therapeutics
Sumayah Jamal's Company Details
ENB Therapeutics logo, ENB Therapeutics contact details

ENB Therapeutics

New York, NY, US • 5 - 9 Employees
Major Drugs

ENB Therapeutics is developing therapies to break drug resistance that occurs in over 50% of cancer patients. Our lead product, ENB-001, is a first-in-class, selective small molecule endothelin B receptor (ETBR) inhibitor shown in multiple preclinical studies to significantly reduce tumor growth and prolong survival in cancer animal models. ENB-001 is the key to unlock the full therapeutic potential of immunotherapy by restoring the ability of T-cells to infiltrate tumors, inhibiting metastasis and prolonging patient survival. Granted Orphan Drug Designation by FDA in 2016, ENB-001 has solid market exclusivity and strong IP. A low cost, time efficient development program provides near-term POC within 18 months from financing. A companion diagnostic will detect ETBR pathway over-expressers creating additional opportunities for indication expansion into multiple tumor types and broader participation in the multi-billion-dollar immunotherapy market.

Pharmaceuticals Biotechnology Nanotechnology
Details about ENB Therapeutics
Frequently Asked Questions about Sumayah Jamal
Sumayah Jamal currently works for ENB Therapeutics.
Sumayah Jamal's role at ENB Therapeutics is President, Co-Founder, Chief Scientific Officer.
Sumayah Jamal's email address is ***@enbpharma.com. To view Sumayah Jamal's full email address, please signup to ConnectPlex.
Sumayah Jamal works in the Pharmaceuticals industry.
Sumayah Jamal's colleagues at ENB Therapeutics are Sandy Harm, Ashok Kumar, Jackson Gibbs and others.
Sumayah Jamal's phone number is 212-792-2317
See more information about Sumayah Jamal